pharma news

News

Jeito's founder and president, Dr Rafaèle Tordjman

Jeito closes 'record' $1.2bn Europe-focused biopharma fund

Jeito Capital has closed its second fund, raking in €1bn, which it claims is the largest ever raise for an independent European biopharma fund.

News

EU invests €30m to fight antimicrobial resistance

The EU has pledged €30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

News

US judge blocks bid to curb abortion pill access

A bid to limit access to the abortion pill mifepristone in the US, while the FDA carries out a review of the drug, has been blocked in the courts.

News

Gilead strikes again, penning $5bn deal to buy Tubulis

Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.

News

Kennedy changes vaccine panel charter after legal setback

A change to the ACIP charter has raised concerns of even greater political influence over the vaccine panel by HHS Secretary Kennedy.

News

AI giant Anthropic buys Coefficient Bio for $400m

Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio.

Jeito closes 'record' $1.2bn Europe-focused biopharma fund

EU invests €30m to fight antimicrobial resistance

US judge blocks bid to curb abortion pill access

Gilead strikes again, penning $5bn deal to buy Tubulis

Kennedy changes vaccine panel charter after legal setback

AI giant Anthropic buys Coefficient Bio for $400m

Amazon puts $100m into global health drive

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks